Olympus ESG-300 Quick Reference Manual

ESG-300 and APU-300

Set Screen Monopolar*

Electrosurgical Generator

ESG-300

QUICK REFERENCE GUIDE

for Gastroenterology

Bipolar

Monopolar

Neutral

Argon

Graphical User
Interface

Purge button

Argon Plasma Unit
“APU-300”

Electrosurgical
Generator
“ESG-300”

Active mode

Active socket

Contact Quality Monitor

System setup

Open user defined settings

Effect level adjustment

Power adjustment

Procedure name

Setting name

Change output socket

* Please refer to Instruction for Use of ESG-300 for detailed information about Bipolar and Argon Set Screens.

ESG-300 Operation Settings

Basic Procedures

Procedure Instrument or technique Mode Power Effect

Snare Polypectomy:
Sessile polyp

Close the snare
slowly and gently

PulseCut Slow 120 2

Snare Polypectomy:
Pedunculated polyp

Close the snare
slowly and gently

ForcedCoag 20 4

Endoscopic Mucosal
Resection (EMR)

Close the snare
slowly and gently

PulseCut Slow 120 2

Hemostasis

Coagrasper SoftCoag 50 3

Sphincterotomy / Pre-Cut

Sphincterotome / Needle
Knife

PulseCut Fast 120 2

Procedure Steps Instrument or technique Mode Power Effect

Marking

Knife (apply gentle pressure)

ForcedCoag 20 2

SoftCoag 50 3

Pre-Cut / Incision

Knife

PulseCut Fast 120 2

BlendCut 30 2

Submucosal Dissection

Knife PowerCoag 30 2

Hemostasis

Closed Knife PowerCoag 30 2

Endoscopic Submucosal Dissection (ESD)

Peroral Endoscopic Myotomy (POEM)

Procedure Steps Instrument or technique Mode Power Effect

Incision

Knife PulseCut Fast 120 2

Dissection / Tunneling

Knife SprayCoag 40 2

Myotomy

Knife PulseCut Fast 120 2

Hemostasis

Coagrasper SoftCoag 50 3

The above settings are examples based upon previous general clinical usage of the device. Please note that clinical staff are solely responsible for selection of an
appropriate mode and power level, dependent upon the instrument being used and the condition of the tissue being treated. Due to the heterogeneity of instruments
and clinical conditions, Olympus cannot accept liability for clinical risks arising from the use of these example settings.